79276870 - SPEEDX

Information

  • Trademark
  • 79276870
  • Serial Number
    79276870
  • Registration Number
    6219009
  • Filing Date
    September 12, 2019
    5 years ago
  • Registration Date
    December 15, 2020
    4 years ago
  • Transaction Date
    August 08, 2022
    2 years ago
  • Status Date
    December 15, 2020
    4 years ago
  • Published for Opposition Date
    September 29, 2020
    4 years ago
  • Location Date
    November 17, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PETITIONS OFFICE
    Employee Name
    FRENCH, CURTIS W
  • Attorney Docket Number
    T-4576 US MP
    Attorney Name
    Joi A. White
    Law Office Assigned Location Code
    O30
  • Owners
Mark Drawing Code
3000
Mark Identification
SPEEDX
Case File Statements
  • DM0000: The mark consists of the following: the wording "SpeeDx" with the wording in black except for one diagonal line of the letter "X" which is blue. A stylized DNA strand of blue and purple is to the left of the wording. White is used for the background but is not claimed as a feature of the mark.
  • GS0051: Pharmaceutical and veterinary preparations and substances; biological chemical test kits comprised of reagents and assays for medical laboratory use in analysis that test for the presence of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes; enzymes for pharmaceutical, veterinary and medical purposes; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; clinical diagnostics for medical or veterinary use
  • PM0001: SPEED
  • CC0000: The color(s) blue, purple and black is/are claimed as a feature of the mark.
  • GS0011: Chemical preparations used in industry, science, photography, agriculture, horticulture and forestry, except fungicides, herbicides, insecticides, and parasiticides; reagents and reactants for non-medical purposes; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acids for other than medical and veterinary purposes; acids namely inorganic acids for industrial purposes; DNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring
  • GS0441: Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to dna, genetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; medical diagnostic imaging and molecular medicine services
  • GS0101: Surgical, medical and veterinary apparatus and instruments; medical and veterinary apparatus and instruments being diagnostic testing apparatus and instruments for medical purposes; diagnostic testing kits containing diagnostic testing apparatus; point of care medical devices; screening kits in this class consisting of medical screening and testing apparatus for the diagnosis of disease, detection and/or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy
  • GS0421: Scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, scientific research consulting in the field of genetics; laboratory analysis in the field of chemistry; development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, dna, rna, protein, polynucleic acid and molecular analysis and evaluation services; dna and rna and polynucleic acid and protein sequencing, analysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; genetic research; scientific and medical research and development services; custom design and development of biochemical assays; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services, namely, chemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; molecular diagnostics testing
Case File Event Statements
  • 8/8/2022 - 2 years ago
    33 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 8/8/2022 - 2 years ago
    32 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 8/8/2022 - 2 years ago
    31 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 8/13/2021 - 3 years ago
    30 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 4/12/2021 - 3 years ago
    29 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 3/18/2021 - 3 years ago
    28 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 3/18/2021 - 3 years ago
    27 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 3/15/2021 - 3 years ago
    26 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 12/15/2020 - 4 years ago
    25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 11/17/2020 - 4 years ago
    24 - CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED Type: CHPB
  • 11/17/2020 - 4 years ago
    23 - ASSIGNED TO PETITION STAFF Type: APET
  • 10/30/2020 - 4 years ago
    22 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA
  • 9/29/2020 - 4 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/29/2020 - 4 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/9/2020 - 4 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 8/25/2020 - 4 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/22/2020 - 4 years ago
    17 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/21/2020 - 4 years ago
    16 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/21/2020 - 4 years ago
    15 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/13/2020 - 4 years ago
    14 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 8/13/2020 - 4 years ago
    13 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 8/13/2020 - 4 years ago
    12 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 8/13/2020 - 4 years ago
    11 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 8/13/2020 - 4 years ago
    10 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 3/13/2020 - 4 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/23/2020 - 4 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/22/2020 - 4 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 1/31/2020 - 4 years ago
    6 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 1/30/2020 - 4 years ago
    5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 1/29/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/27/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/27/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 1/23/2020 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR